SciClone Pharmaceuticals, Inc. Stock

Stocks

17-10-13	SciClone Pharmaceuticals : Consortium Led By GL Capital Completes Acquisition Of SciClone	PR
17-08-29	Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017	BU
17-08-16	SciClone Pharmaceuticals : Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma	PR
17-08-10	SciClone Pharmaceuticals : Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties	PR
17-08-09	SciClone Pharmaceuticals : Reports Second Quarter 2017 Financial Results	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCICLONE PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	+2.75%	+4.79%	+61.44%	+127.46%	1,133B
JOHNSON & JOHNSON	+4.21%	+6.39%	+39.66%	+77.99%	621B
ABBVIE INC.	-0.19%	+0.54%	+24.60%	+96.87%	503B
ROCHE HOLDING AG	+0.03%	+3.27%	+39.79%	+65.06%	379B
MERCK & CO., INC.	-1.04%	+2.28%	+69.50%	+43.68%	370B
NOVARTIS AG	+1.58%	+2.37%	+22.91%	+52.52%	292B
ASTRAZENECA PLC	+2.90%	+2.22%	+3.51%	+28.51%	262B
AMGEN INC.	+2.27%	+3.48%	+51.74%	+64.48%	237B
GILEAD SCIENCES, INC.	+2.03%	-0.25%	+29.24%	+102.39%	190B
Average	+1.42%	+3.22%	+38.04%	+73.22%	443.11B
Weighted average by Cap.	+1.84%	+3.73%	+43.34%	+85.26%